China Botulinum Toxin Type A Market Size, Share & Trends Analysis Report By Application (Upper Face, Mid Face, Lower Face, Body), By Gender (Female, Male), By Age (Below 30 Years, 31 to 59 Years, Over 60 Years), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                         1.2.1. Application
                         1.2.2. Gender
                         1.2.3. Age
                         1.2.4. End Use
                         1.2.5. Estimates and forecast timeline.
                    1.3. Research Methodology
                    1.4. Information Procurement
                         1.4.1. Purchased database
                         1.4.2. GVR’s internal database
                         1.4.3. Secondary sources
                         1.4.4. Primary research
                         1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                         1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                         1.7.1. Commodity price analysis (Model 1)
                         1.7.2. Approach 1: Commodity flow approach
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                         2.2.1. Application Segment
                         2.2.2. Gender Segment
                         2.2.3. Age Segment
                         2.2.4. End Use Segment
                    2.3. Competitive Insights
Chapter 3. China Botulinum Toxin Type A Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                         3.1.1. Parent market outlook
                         3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                         3.2.1. Market driver analysis
                              3.2.1.1. Increasing demand for aesthetic procedures
                              3.2.1.2. Advancements in technology and techniques
                              3.2.1.3. Rising disposable income
                         3.2.2. Market restraint analysis
                              3.2.2.1. Stringent Regulatory Policies
                              3.2.2.2. Declining Number Of Aesthetic Practices
                    3.3. China Botulinum Toxin Type A Market Analysis Tools
                         3.3.1. Industry Analysis - Porter’s
                              3.3.1.1. Supplier power
                              3.3.1.2. Buyer power
                              3.3.1.3. Substitution threat
                              3.3.1.4. Threat of new entrant
                              3.3.1.5. Competitive rivalry
                         3.3.2. PESTEL Analysis
                              3.3.2.1. Political landscape
                              3.3.2.2. Technological landscape
                              3.3.2.3. Economic landscape
Chapter 4. China Botulinum Toxin Type A Market: Application Estimates & Trend Analysis
                    4.1. China Botulinum Toxin Type A Market: Application Dashboard
                    4.2. China Botulinum Toxin Type A Market: Application Movement Analysis
                    4.3. China Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    4.4. Upper Face
                         4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                              4.4.1.1. Glabellar Wrinkles
                                   4.4.1.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
                              4.4.1.2. Forehead Wrinkles
                                   4.4.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
                              4.4.1.3. Crow’s Feet
                                   4.4.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    4.5. Mid Face
                         4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    4.6. Lower Face
                         4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    4.7. Body
                         4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. China Botulinum Toxin Type A Market: Gender Estimates & Trend Analysis
                    5.1. China Botulinum Toxin Type A Market: Gender Dashboard
                    5.2. China Botulinum Toxin Type A Market: Gender Movement Analysis
                    5.3. China Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by Gender, 2018 to 2030 (USD Million)
                    5.4. Female
                         5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    5.5. Male
                         5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. China Botulinum Toxin Type A Market: Age Estimates & Trend Analysis
                    6.1. China Botulinum Toxin Type A Market: Age Dashboard
                    6.2. China Botulinum Toxin Type A Market: Age Movement Analysis
                    6.3. China Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by Age, 2018 to 2030 (USD Million)
                    6.4. Below 30 Years
                         6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    6.5. 31 to 59 Years
                         6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    6.6. Over 60 Years
                         6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. China Botulinum Toxin Type A Market: End Use Estimates & Trend Analysis
                    7.1. China Botulinum Toxin Type A Market: End Use Dashboard
                    7.2. China Botulinum Toxin Type A Market: End Use Movement Analysis
                    7.3. China Botulinum Toxin Type A Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
                    7.4. Hospitals
                         7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    7.5. Clinics & Aesthetic Centers
                         7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
                    7.6. Medspas
                         7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Manufacturers
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                         8.3.1. List of key distributors and channel partners
                         8.3.2. Key customers
                         8.3.3. Key company market share analysis, 2023
                         8.3.4. Hugel
                              8.3.4.1. Company overview
                              8.3.4.2. Financial performance
                              8.3.4.3. Product benchmarking
                              8.3.4.4. Strategic initiatives
                         8.3.5. Medytox
                              8.3.5.1. Company overview
                              8.3.5.2. Financial performance
                              8.3.5.3. Product benchmarking
                              8.3.5.4. Strategic initiatives
                         8.3.6. Daewoong
                              8.3.6.1. Company overview
                              8.3.6.2. Financial performance
                              8.3.6.3. Product benchmarking
                              8.3.6.4. Strategic initiatives
                         8.3.7. Galderma
                              8.3.7.1. Company overview
                              8.3.7.2. Financial performance
                              8.3.7.3. Product benchmarking
                              8.3.7.4. Strategic initiatives
                         8.3.8. Huons Global
                              8.3.8.1. Company overview
                              8.3.8.2. Financial performance
                              8.3.8.3. Product benchmarking
                              8.3.8.4. Strategic initiatives
                         8.3.9. Pharma Research BIO
                              8.3.9.1. Company overview
                              8.3.9.2. Financial performance
                              8.3.9.3. Product benchmarking
                              8.3.9.4. Strategic initiatives
                         8.3.10. AbbVie
                              8.3.10.1. Company overview
                              8.3.10.2. Financial performance
                              8.3.10.3. Product benchmarking
                              8.3.10.4. Strategic initiatives
                         8.3.11. Sinopharm Group
                              8.3.11.1. Company overview
                              8.3.11.2. Financial performance
                              8.3.11.3. Product benchmarking
                              8.3.11.4. Strategic initiatives
                         8.3.12. Huadong Medicine
                              8.3.12.1. Company overview
                              8.3.12.2. Financial performance
                              8.3.12.3. Product benchmarking
                              8.3.12.4. Strategic initiatives
                         8.3.13. Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
                              8.3.13.1. Company overview
                              8.3.13.2. Financial performance
                              8.3.13.3. Product benchmarking
                              8.3.13.4. Strategic initiatives
                         8.3.14. Merz Pharma.
                              8.3.14.1. Company overview
                              8.3.14.2. Financial performance
                              8.3.14.3. Product benchmarking
                              8.3.14.4. Strategic initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. China botulinum toxin type a market, by application, 2018 - 2030 (USD Million)
Table 4. China botulinum toxin type a market, by gender, 2018 - 2030 (USD Million)
Table 5. China botulinum toxin type a market, by age, 2018 - 2030 (USD Million)
Table 6. China botulinum toxin type a market, by end-use, 2018 - 2030 (USD Million)
Table 7. Participant’s overview
Table 8. Financial performance
Table 9. Key companies undergoing expansions
Table 10. Key companies undergoing acquisitions
Table 11. Key companies undergoing collaborations
Table 12. Key companies launching new products/services
Table 13. Key companies undergoing partnerships
Table 14. Key companies undertaking other strategies

List of Figures

Fig. 1 China botulinum toxin type A market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 China botulinum toxin type a market revenues, 2023, (USD Billions)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 China botulinum toxin type A market: application outlook
Fig. 14 China upper face market, 2018 - 2030 (USD Billion)
Fig. 15 China glabellar wrinkles market, 2018 - 2030 (USD Billion)
Fig. 16 China forehead wrinkles market, 2018 - 2030 (USD Billion)
Fig. 17 China crow’s feet market, 2018 - 2030 (USD Billion)
Fig. 18 China mid face market, 2018 - 2030 (USD Billion)
Fig. 19 China lower face market, 2018 - 2030 (USD Billion)
Fig. 20 China body market, 2018 - 2030 (USD Billion)
Fig. 21 China botulinum toxin type A market: gender movement analysis
Fig. 22 China female market, 2018 - 2030 (USD Billion)
Fig. 23 China male market, 2018 - 2030 (USD Billion)
Fig. 24 China botulinum toxin type A market: age outlook
Fig. 25 China below 30 years market, 2018 - 2030 (USD Billion)
Fig. 26 China 31 to 59 years market, 2018 - 2030 (USD Billion)
Fig. 27 China over 60 years market, 2018 - 2030 (USD Billion)
Fig. 28 China botulinum toxin type A market: end-use movement analysis
Fig. 29 China hospitals market, 2018 - 2030 (USD Billion)
Fig. 30 China clinics & aesthetic centers market, 2018 - 2030 (USD Billion)
Fig. 31 China medspas market, 2018 - 2030 (USD Billion)
Fig. 32 Segment dashboard
Fig. 33 Market participant categorization
Fig. 34 Strategy mapping